sonar-pro
Permits stability data submission for pharmaceutical products at 25°C/60% relative humidity (RH) when supported by accelerated stability studies.
{
  "id": "f7ef72a0-c1f9-4015-aafc-e6ec2484e14c",
  "choices": [
    {
      "finish_reason": "stop",
      "index": 0,
      "logprobs": null,
      "message": {
        "content": "{\"status\": \"NO\", \"explanation\": \"Cambodia generally follows WHO guidelines, which require long-term stability data at 30°C/75% RH for registration; stability data at 25°C/60% RH is not normally sufficient, even when supported by accelerated studies, unless specifically justified and approved by the national regulatory authority.\"}",
        "refusal": null,
        "role": "assistant",
        "annotations": null,
        "audio": null,
        "function_call": null,
        "tool_calls": null
      },
      "delta": {
        "role": "assistant",
        "content": ""
      }
    }
  ],
  "created": 1755750250,
  "model": "sonar-pro",
  "object": "chat.completion",
  "service_tier": null,
  "system_fingerprint": null,
  "usage": {
    "completion_tokens": 69,
    "prompt_tokens": 31,
    "total_tokens": 100,
    "completion_tokens_details": null,
    "prompt_tokens_details": null,
    "search_context_size": "low",
    "cost": {
      "input_tokens_cost": 0.0,
      "output_tokens_cost": 0.001,
      "request_cost": 0.006,
      "total_cost": 0.007
    }
  },
  "citations": [
    "https://humiditycontrol.com/blog/what-is-stability-testing/",
    "https://www.zamra.co.zm/wp-content/uploads/2023/05/Marketing-Authorisation-STABILITY-GUIDELINES.pdf",
    "https://www.rsc.org/suppdata/c5/ra/c5ra07716h/c5ra07716h1.pdf",
    "https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-r2-stability-testing-new-drug-substances-and-products-step-5_en.pdf",
    "http://academy.gmp-compliance.org/guidemgr/files/WHO_TRS_953_Annex2.pdf"
  ],
  "search_results": [
    {
      "title": "Stability Testing for Pharmaceuticals & More",
      "url": "https://humiditycontrol.com/blog/what-is-stability-testing/",
      "date": "2023-02-22",
      "last_updated": "2025-06-16"
    },
    {
      "title": "[PDF] ANNEX 11 * Guidelines for stability testing of pharmaceutical ...",
      "url": "https://www.zamra.co.zm/wp-content/uploads/2023/05/Marketing-Authorisation-STABILITY-GUIDELINES.pdf",
      "date": null,
      "last_updated": "2025-04-14"
    },
    {
      "title": "Annex 2 Stability testing of active pharmaceutical ...",
      "url": "https://www.rsc.org/suppdata/c5/ra/c5ra07716h/c5ra07716h1.pdf",
      "date": null,
      "last_updated": "2025-03-27"
    },
    {
      "title": "[PDF] Q 1 A (R2) Stability Testing of new Drug Substances and Products",
      "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-r2-stability-testing-new-drug-substances-and-products-step-5_en.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    },
    {
      "title": "Annex 2 Stability testing of active pharmaceutical ...",
      "url": "http://academy.gmp-compliance.org/guidemgr/files/WHO_TRS_953_Annex2.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    }
  ]
}